Bristol Myers Squibb is undervalued despite challenges. Learn how BMY stock's strong pipeline, cash flow, and growth ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the 10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio.

Bristol Myers Squibb to cut 68 jobs in Lawrenceville as part of a broader restructuring effort aiming to slash $2B in costs ...

Bristol-Myers Squibb was founded in 1858 and has grown to be one of today's leading global pharmaceutical companies.

An argument at a Cumberland Farms. A meeting at a Raynham Wendy's. License plate readers. How police homed in on a suspect in ...

In the latest trading session, Bristol Myers Squibb (BMY) closed at $47.66, marking a +1.32% move from the previous day. This change outpaced the S&P 500's 0.61% gain on the day. Elsewhere, the Dow ...

NEW YORK (Reuters) - Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for three drugs, 1-1/2 months ...

(Reuters) -Bristol Myers Squibb on Thursday said its 2025 revenue would fall more sharply than Wall Street had forecast due to generic competition for some of its older drugs, sending its share ...

Bristol Myers to Acquire Karuna, a Neuroscience Drugmaker, for $14 Billion The deal is a bet on the growing market for psychiatric and neurological drugs.

Shares of Bristol Myers Squibb Co. BMY slipped 1.55% to $46.88 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.58% ...

Bristol Myers (BMY) Squibb announced results from POETYK PsA-1 and POETYK PsA-2, the pivotal Phase 3 trials evaluating the efficacy and safety of Sotyktu in adults with active psoriatic arthritis ...

Shares of Bristol Myers Squibb Co. BMY advanced 1.80% to $49.82 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 2.51% to ...